Moxifloxacin

Common Uses

Moxifloxacin is used to treat infections caused by certain types of bacteria. It belongs to a class of medications called fluoroquinolone antibiotics, which work by stopping the growth of bacteria. The oral and injectable forms are commonly used for:

• Respiratory tract infections: This includes community-acquired pneumonia, acute bacterial sinusitis, and acute worsening of chronic bronchitis.
• Skin infections: It is used for both complicated and uncomplicated infections of the skin and skin structures.
• Abdominal infections: It is prescribed for complicated intra-abdominal infections.
• Plague: Moxifloxacin is used to treat and prevent plague in adults.

Ophthalmic Use

Moxifloxacin is also available as an eye drop (ophthalmic solution). In this form, it is used to treat bacterial conjunctivitis, which is an infection of the eye often referred to as pink eye.

Usage Considerations

This medication is only effective against bacterial infections. It will not work for viral infections, such as the common cold or the flu. Because fluoroquinolones are associated with serious side effects, healthcare providers may reserve moxifloxacin for conditions like sinusitis or bronchitis only when other treatment options are not appropriate.

Mechanism of Action

Moxifloxacin belongs to a group of medicines called fluoroquinolone antibiotics. It works by killing bacteria or preventing their growth. It achieves this by blocking specific enzymes, known as DNA gyrase and topoisomerase IV, which bacteria require to repair and copy their genetic material.

By disrupting these essential processes, moxifloxacin prevents the bacteria from multiplying. This allows the body's immune system to clear the remaining infection. Because it targets processes specific to bacteria, it is effective against a wide range of bacterial strains.

Limitations

It is important to note that moxifloxacin only works against bacterial infections. It is not effective for treating infections caused by viruses, such as:

• The common cold
• The flu
• Bronchitis caused by a virus

Common Side Effects

Common side effects of moxifloxacin may include:

• Nausea and vomiting
• Diarrhea
• Dizziness
• Headache
• Stomach pain
• Constipation

If you are using moxifloxacin eye drops, you may experience temporary blurred vision, eye dryness, or mild eye irritation.

Serious Side Effects

Moxifloxacin can cause serious side effects that may require immediate medical care. Contact your healthcare provider right away if you notice:

• Tendon and joint issues: Pain, swelling, or inflammation in the tendons, or a sudden snap or pop in a joint.
• Nerve damage: Numbness, tingling, or burning pain in the hands or feet.
• Central nervous system changes: Seizures, tremors, hallucinations, anxiety, or confusion.
• Heart rhythm changes: Fast, pounding, or irregular heartbeats and sudden dizziness.
• Severe allergic reactions: Skin rash, hives, or swelling of the face, lips, or throat.
• Intestinal problems: Severe stomach cramps and watery or bloody diarrhea.
• Liver problems: Yellowing of the skin or eyes, dark urine, or upper stomach pain.

Serious Side Effects

Moxifloxacin is associated with disabling and potentially irreversible serious adverse reactions that can occur together. These include:

• Tendon Issues: Increased risk of tendinitis and tendon rupture, especially the Achilles tendon. This risk is higher in older adults, those taking corticosteroids, or organ transplant recipients.
• Peripheral Neuropathy: Nerve damage in the arms or legs that may cause pain, burning, tingling, or numbness.
• Central Nervous System Effects: Potential for seizures, increased pressure in the head, dizziness, tremors, and psychiatric reactions such as anxiety, confusion, or hallucinations.

Aortic Risks

Fluoroquinolone antibiotics may increase the risk of a tear or rupture in the main artery of the body (aorta). This risk is higher for individuals with a history of blockages or aneurysms, high blood pressure, or certain genetic conditions.

Heart Rhythm Changes

Moxifloxacin can cause a change in the electrical activity of the heart known as QT prolongation. This may lead to a serious or life-threatening irregular heartbeat. The risk is higher for those with low potassium levels or those taking certain other medications.

Other Precautions

• Myasthenia Gravis: This medication may worsen muscle weakness in people with this condition.
• Blood Sugar: Serious changes in blood sugar, including both high and low levels, have been reported, particularly in people with diabetes.
• Hypersensitivity: Severe allergic reactions can occur, sometimes after the first dose.
• Photosensitivity: The skin may become more sensitive to sunlight or UV light, leading to severe sunburns.

Pregnancy

There are no adequate and well-controlled studies regarding the use of moxifloxacin in pregnant women. Animal studies have indicated that the drug may cause adverse effects on fetal development. Consequently, moxifloxacin is usually reserved for situations where the clinical benefit to the mother is considered greater than the potential risk to the unborn baby.

Individuals who are pregnant or planning to become pregnant should consult their healthcare provider to evaluate the necessity of the treatment and explore alternative options if appropriate.

Breastfeeding

It is not known whether moxifloxacin is excreted in human breast milk, though it has been found in the milk of animal subjects. Due to the risk of serious adverse reactions in nursing infants, healthcare providers generally recommend either discontinuing breastfeeding or stopping the medication.

When deciding between breastfeeding and continuing moxifloxacin therapy, patients and providers should consider:

• The clinical necessity of the drug for the mother.
• The potential for adverse effects on the nursing child.

Available Forms

Moxifloxacin is provided in the following forms:

• Oral Tablet: A film-coated tablet taken by mouth.
• Intravenous Injection: A sterile solution for infusion into a vein, often provided in a premixed bag.

FDA Approval and Indications

Moxifloxacin is approved by the U.S. Food and Drug Administration (FDA) for the treatment of several types of bacterial infections in adults. These include community-acquired pneumonia, acute skin and skin structure infections, and complicated intra-abdominal infections. It is also available as an ophthalmic solution for the treatment of bacterial conjunctivitis.

Boxed Warning

The FDA has issued a boxed warning for moxifloxacin and other fluoroquinolones because they are associated with disabling and potentially irreversible serious adverse reactions that can occur together. These include:

• Tendinitis and tendon rupture: Increased risk of tendon inflammation or tears, especially in older adults or those taking corticosteroids.
• Peripheral neuropathy: Nerve damage that can cause pain, burning, or tingling in the extremities.
• Central nervous system effects: Risks include seizures, hallucinations, and anxiety.

Because of these risks, the FDA recommends that moxifloxacin be reserved for patients with certain conditions, such as acute bacterial sinusitis or acute worsening of chronic bronchitis, only when no other treatment options are available.

Additional Safety Communications

The FDA has also warned that fluoroquinolones can increase the risk of tears or ruptures in the aorta, the main artery of the body. These events are rare but can be fatal. Patients with a history of aneurysms or certain vascular diseases may be at higher risk.

Risk Summary

There are no adequate and well-controlled studies of moxifloxacin use in pregnant women. Because of the lack of human data, healthcare providers typically only prescribe this medication during pregnancy if the clinical need is clear and other safer alternatives are not available.

Animal Data and Concerns

Animal studies have shown that moxifloxacin may cause potential harm to a fetus when administered at high doses. These findings include:

• Decreased fetal body weight.
• Increased incidence of skeletal variations or delays in bone development.
• Increased risk of pregnancy loss.

Moxifloxacin belongs to a class of antibiotics called fluoroquinolones. There are general medical concerns regarding this class of drugs and their potential impact on the development of joints and cartilage in a growing fetus, although human evidence is limited. If you are pregnant or planning to become pregnant, you should discuss the risks and benefits of this treatment with your doctor before use.